Global Anti-Obesity Drugs Sales Market Report 2018

March 2018 | 110 pages | ID: G6D9541494AEN
QYResearch

Abstracts

In this report, the global Anti-Obesity Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Anti-Obesity Drugs for these regions, from 2013 to 2025 (forecast), covering

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Global Anti-Obesity Drugs market competition by top manufacturers/players, with Anti-Obesity Drugs sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Merck
• F.Hoffmann-La Roche
• GlaxoSmithKline
• AstraZeneca
• Boehringer Ingelheim
• Novo Nordisk
• Eisai
• Norgine
• Arena Pharmaceuticals
• Orexigen Therapeutics
• Vivus
• Alizyme
• Rhythm Pharmaceuticals
• Shionogi
• Zafgan

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Prescription Drugs
• OTC drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• 6-18 Callant
• 18-30 Adult
• 30-60Middle-Aged
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Anti-Obesity Drugs Sales Market Report 2018

1 ANTI-OBESITY DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Anti-Obesity Drugs
1.2 Classification of Anti-Obesity Drugs by Product Category
  1.2.1 Global Anti-Obesity Drugs Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 Global Anti-Obesity Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Prescription Drugs
  1.2.4 OTC drugs
1.3 Global Anti-Obesity Drugs Market by Application/End Users
  1.3.1 Global Anti-Obesity Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 6-18 Callant
  1.3.3 18-30 Adult
  1.3.4 30-60Middle-Aged
  1.3.5 Others
1.4 Global Anti-Obesity Drugs Market by Region
  1.4.1 Global Anti-Obesity Drugs Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 United States Anti-Obesity Drugs Status and Prospect (2013-2025)
  1.4.3 China Anti-Obesity Drugs Status and Prospect (2013-2025)
  1.4.4 Europe Anti-Obesity Drugs Status and Prospect (2013-2025)
  1.4.5 Japan Anti-Obesity Drugs Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Anti-Obesity Drugs Status and Prospect (2013-2025)
  1.4.7 India Anti-Obesity Drugs Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Anti-Obesity Drugs (2013-2025)
  1.5.1 Global Anti-Obesity Drugs Sales and Growth Rate (2013-2025)
  1.5.2 Global Anti-Obesity Drugs Revenue and Growth Rate (2013-2025)

2 GLOBAL ANTI-OBESITY DRUGS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Anti-Obesity Drugs Market Competition by Players/Suppliers
  2.1.1 Global Anti-Obesity Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Global Anti-Obesity Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Anti-Obesity Drugs (Volume and Value) by Type
  2.2.1 Global Anti-Obesity Drugs Sales and Market Share by Type (2013-2018)
  2.2.2 Global Anti-Obesity Drugs Revenue and Market Share by Type (2013-2018)
2.3 Global Anti-Obesity Drugs (Volume and Value) by Region
  2.3.1 Global Anti-Obesity Drugs Sales and Market Share by Region (2013-2018)
  2.3.2 Global Anti-Obesity Drugs Revenue and Market Share by Region (2013-2018)
2.4 Global Anti-Obesity Drugs (Volume) by Application

3 UNITED STATES ANTI-OBESITY DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Anti-Obesity Drugs Sales and Value (2013-2018)
  3.1.1 United States Anti-Obesity Drugs Sales and Growth Rate (2013-2018)
  3.1.2 United States Anti-Obesity Drugs Revenue and Growth Rate (2013-2018)
  3.1.3 United States Anti-Obesity Drugs Sales Price Trend (2013-2018)
3.2 United States Anti-Obesity Drugs Sales Volume and Market Share by Players (2013-2018)
3.3 United States Anti-Obesity Drugs Sales Volume and Market Share by Type (2013-2018)
3.4 United States Anti-Obesity Drugs Sales Volume and Market Share by Application (2013-2018)

4 CHINA ANTI-OBESITY DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Anti-Obesity Drugs Sales and Value (2013-2018)
  4.1.1 China Anti-Obesity Drugs Sales and Growth Rate (2013-2018)
  4.1.2 China Anti-Obesity Drugs Revenue and Growth Rate (2013-2018)
  4.1.3 China Anti-Obesity Drugs Sales Price Trend (2013-2018)
4.2 China Anti-Obesity Drugs Sales Volume and Market Share by Players (2013-2018)
4.3 China Anti-Obesity Drugs Sales Volume and Market Share by Type (2013-2018)
4.4 China Anti-Obesity Drugs Sales Volume and Market Share by Application (2013-2018)

5 EUROPE ANTI-OBESITY DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Anti-Obesity Drugs Sales and Value (2013-2018)
  5.1.1 Europe Anti-Obesity Drugs Sales and Growth Rate (2013-2018)
  5.1.2 Europe Anti-Obesity Drugs Revenue and Growth Rate (2013-2018)
  5.1.3 Europe Anti-Obesity Drugs Sales Price Trend (2013-2018)
5.2 Europe Anti-Obesity Drugs Sales Volume and Market Share by Players (2013-2018)
5.3 Europe Anti-Obesity Drugs Sales Volume and Market Share by Type (2013-2018)
5.4 Europe Anti-Obesity Drugs Sales Volume and Market Share by Application (2013-2018)

6 JAPAN ANTI-OBESITY DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Anti-Obesity Drugs Sales and Value (2013-2018)
  6.1.1 Japan Anti-Obesity Drugs Sales and Growth Rate (2013-2018)
  6.1.2 Japan Anti-Obesity Drugs Revenue and Growth Rate (2013-2018)
  6.1.3 Japan Anti-Obesity Drugs Sales Price Trend (2013-2018)
6.2 Japan Anti-Obesity Drugs Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Anti-Obesity Drugs Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Anti-Obesity Drugs Sales Volume and Market Share by Application (2013-2018)

7 SOUTHEAST ASIA ANTI-OBESITY DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Anti-Obesity Drugs Sales and Value (2013-2018)
  7.1.1 Southeast Asia Anti-Obesity Drugs Sales and Growth Rate (2013-2018)
  7.1.2 Southeast Asia Anti-Obesity Drugs Revenue and Growth Rate (2013-2018)
  7.1.3 Southeast Asia Anti-Obesity Drugs Sales Price Trend (2013-2018)
7.2 Southeast Asia Anti-Obesity Drugs Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Anti-Obesity Drugs Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Anti-Obesity Drugs Sales Volume and Market Share by Application (2013-2018)

8 INDIA ANTI-OBESITY DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Anti-Obesity Drugs Sales and Value (2013-2018)
  8.1.1 India Anti-Obesity Drugs Sales and Growth Rate (2013-2018)
  8.1.2 India Anti-Obesity Drugs Revenue and Growth Rate (2013-2018)
  8.1.3 India Anti-Obesity Drugs Sales Price Trend (2013-2018)
8.2 India Anti-Obesity Drugs Sales Volume and Market Share by Players (2013-2018)
8.3 India Anti-Obesity Drugs Sales Volume and Market Share by Type (2013-2018)
8.4 India Anti-Obesity Drugs Sales Volume and Market Share by Application (2013-2018)

9 GLOBAL ANTI-OBESITY DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Pfizer
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Anti-Obesity Drugs Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Pfizer Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.1.4 Main Business/Business Overview
9.2 Merck
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Anti-Obesity Drugs Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Merck Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.2.4 Main Business/Business Overview
9.3 F.Hoffmann-La Roche
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Anti-Obesity Drugs Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 F.Hoffmann-La Roche Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.3.4 Main Business/Business Overview
9.4 GlaxoSmithKline
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Anti-Obesity Drugs Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 GlaxoSmithKline Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.4.4 Main Business/Business Overview
9.5 AstraZeneca
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Anti-Obesity Drugs Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 AstraZeneca Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.5.4 Main Business/Business Overview
9.6 Boehringer Ingelheim
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Anti-Obesity Drugs Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Boehringer Ingelheim Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.6.4 Main Business/Business Overview
9.7 Novo Nordisk
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Anti-Obesity Drugs Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Novo Nordisk Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.7.4 Main Business/Business Overview
9.8 Eisai
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Anti-Obesity Drugs Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Eisai Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.8.4 Main Business/Business Overview
9.9 Norgine
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Anti-Obesity Drugs Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Norgine Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.9.4 Main Business/Business Overview
9.10 Arena Pharmaceuticals
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Anti-Obesity Drugs Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Arena Pharmaceuticals Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  9.10.4 Main Business/Business Overview
9.11 Orexigen Therapeutics
9.12 Vivus
9.13 Alizyme
9.14 Rhythm Pharmaceuticals
9.15 Shionogi
9.16 Zafgan

10 ANTI-OBESITY DRUGS MAUFACTURING COST ANALYSIS

10.1 Anti-Obesity Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Anti-Obesity Drugs
10.3 Manufacturing Process Analysis of Anti-Obesity Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Anti-Obesity Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Anti-Obesity Drugs Major Manufacturers in 2017
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL ANTI-OBESITY DRUGS MARKET FORECAST (2018-2025)

14.1 Global Anti-Obesity Drugs Sales Volume, Revenue and Price Forecast (2018-2025)
  14.1.1 Global Anti-Obesity Drugs Sales Volume and Growth Rate Forecast (2018-2025)
  14.1.2 Global Anti-Obesity Drugs Revenue and Growth Rate Forecast (2018-2025)
  14.1.3 Global Anti-Obesity Drugs Price and Trend Forecast (2018-2025)
14.2 Global Anti-Obesity Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  14.2.1 Global Anti-Obesity Drugs Sales Volume and Growth Rate Forecast by Regions (2018-2025)
  14.2.2 Global Anti-Obesity Drugs Revenue and Growth Rate Forecast by Regions (2018-2025)
  14.2.3 United States Anti-Obesity Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.4 China Anti-Obesity Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.5 Europe Anti-Obesity Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.6 Japan Anti-Obesity Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.7 Southeast Asia Anti-Obesity Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.8 India Anti-Obesity Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Anti-Obesity Drugs Sales Volume, Revenue and Price Forecast by Type (2018-2025)
  14.3.1 Global Anti-Obesity Drugs Sales Forecast by Type (2018-2025)
  14.3.2 Global Anti-Obesity Drugs Revenue Forecast by Type (2018-2025)
  14.3.3 Global Anti-Obesity Drugs Price Forecast by Type (2018-2025)
14.4 Global Anti-Obesity Drugs Sales Volume Forecast by Application (2018-2025)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Anti-Obesity Drugs
Figure Global Anti-Obesity Drugs Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Anti-Obesity Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Prescription Drugs Product Picture
Figure OTC drugs Product Picture
Figure Global Anti-Obesity Drugs Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Anti-Obesity Drugs by Application in 2017
Figure 6-18 Callant Examples
Table Key Downstream Customer in 6-18 Callant
Figure 18-30 Adult Examples
Table Key Downstream Customer in 18-30 Adult
Figure 30-60Middle-Aged Examples
Table Key Downstream Customer in 30-60Middle-Aged
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Anti-Obesity Drugs Market Size (Million USD) by Regions (2013-2025)
Figure United States Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Anti-Obesity Drugs Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Anti-Obesity Drugs Sales Volume (K Units) (2013-2018)
Table Global Anti-Obesity Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Anti-Obesity Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Anti-Obesity Drugs Sales Share by Players/Suppliers
Figure 2017 Anti-Obesity Drugs Sales Share by Players/Suppliers
Figure Global Anti-Obesity Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Anti-Obesity Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Anti-Obesity Drugs Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Anti-Obesity Drugs Revenue Share by Players
Table 2017 Global Anti-Obesity Drugs Revenue Share by Players
Table Global Anti-Obesity Drugs Sales (K Units) and Market Share by Type (2013-2018)
Table Global Anti-Obesity Drugs Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Anti-Obesity Drugs by Type (2013-2018)
Figure Global Anti-Obesity Drugs Sales Growth Rate by Type (2013-2018)
Table Global Anti-Obesity Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Anti-Obesity Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Anti-Obesity Drugs by Type (2013-2018)
Figure Global Anti-Obesity Drugs Revenue Growth Rate by Type (2013-2018)
Table Global Anti-Obesity Drugs Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Anti-Obesity Drugs Sales Share by Region (2013-2018)
Figure Sales Market Share of Anti-Obesity Drugs by Region (2013-2018)
Figure Global Anti-Obesity Drugs Sales Growth Rate by Region in 2017
Table Global Anti-Obesity Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Anti-Obesity Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Anti-Obesity Drugs by Region (2013-2018)
Figure Global Anti-Obesity Drugs Revenue Growth Rate by Region in 2017
Table Global Anti-Obesity Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Anti-Obesity Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Anti-Obesity Drugs by Region (2013-2018)
Figure Global Anti-Obesity Drugs Revenue Market Share by Region in 2017
Table Global Anti-Obesity Drugs Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Anti-Obesity Drugs Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Anti-Obesity Drugs by Application (2013-2018)
Figure Global Anti-Obesity Drugs Sales Market Share by Application (2013-2018)
Figure United States Anti-Obesity Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure United States Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Anti-Obesity Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table United States Anti-Obesity Drugs Sales Volume (K Units) by Players (2013-2018)
Table United States Anti-Obesity Drugs Sales Volume Market Share by Players (2013-2018)
Figure United States Anti-Obesity Drugs Sales Volume Market Share by Players in 2017
Table United States Anti-Obesity Drugs Sales Volume (K Units) by Type (2013-2018)
Table United States Anti-Obesity Drugs Sales Volume Market Share by Type (2013-2018)
Figure United States Anti-Obesity Drugs Sales Volume Market Share by Type in 2017
Table United States Anti-Obesity Drugs Sales Volume (K Units) by Application (2013-2018)
Table United States Anti-Obesity Drugs Sales Volume Market Share by Application (2013-2018)
Figure United States Anti-Obesity Drugs Sales Volume Market Share by Application in 2017
Figure China Anti-Obesity Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure China Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Anti-Obesity Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table China Anti-Obesity Drugs Sales Volume (K Units) by Players (2013-2018)
Table China Anti-Obesity Drugs Sales Volume Market Share by Players (2013-2018)
Figure China Anti-Obesity Drugs Sales Volume Market Share by Players in 2017
Table China Anti-Obesity Drugs Sales Volume (K Units) by Type (2013-2018)
Table China Anti-Obesity Drugs Sales Volume Market Share by Type (2013-2018)
Figure China Anti-Obesity Drugs Sales Volume Market Share by Type in 2017
Table China Anti-Obesity Drugs Sales Volume (K Units) by Application (2013-2018)
Table China Anti-Obesity Drugs Sales Volume Market Share by Application (2013-2018)
Figure China Anti-Obesity Drugs Sales Volume Market Share by Application in 2017
Figure Europe Anti-Obesity Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Anti-Obesity Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Anti-Obesity Drugs Sales Volume (K Units) by Players (2013-2018)
Table Europe Anti-Obesity Drugs Sales Volume Market Share by Players (2013-2018)
Figure Europe Anti-Obesity Drugs Sales Volume Market Share by Players in 2017
Table Europe Anti-Obesity Drugs Sales Volume (K Units) by Type (2013-2018)
Table Europe Anti-Obesity Drugs Sales Volume Market Share by Type (2013-2018)
Figure Europe Anti-Obesity Drugs Sales Volume Market Share by Type in 2017
Table Europe Anti-Obesity Drugs Sales Volume (K Units) by Application (2013-2018)
Table Europe Anti-Obesity Drugs Sales Volume Market Share by Application (2013-2018)
Figure Europe Anti-Obesity Drugs Sales Volume Market Share by Application in 2017
Figure Japan Anti-Obesity Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Anti-Obesity Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Anti-Obesity Drugs Sales Volume (K Units) by Players (2013-2018)
Table Japan Anti-Obesity Drugs Sales Volume Market Share by Players (2013-2018)
Figure Japan Anti-Obesity Drugs Sales Volume Market Share by Players in 2017
Table Japan Anti-Obesity Drugs Sales Volume (K Units) by Type (2013-2018)
Table Japan Anti-Obesity Drugs Sales Volume Market Share by Type (2013-2018)
Figure Japan Anti-Obesity Drugs Sales Volume Market Share by Type in 2017
Table Japan Anti-Obesity Drugs Sales Volume (K Units) by Application (2013-2018)
Table Japan Anti-Obesity Drugs Sales Volume Market Share by Application (2013-2018)
Figure Japan Anti-Obesity Drugs Sales Volume Market Share by Application in 2017
Figure Southeast Asia Anti-Obesity Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Anti-Obesity Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Anti-Obesity Drugs Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Anti-Obesity Drugs Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Anti-Obesity Drugs Sales Volume Market Share by Players in 2017
Table Southeast Asia Anti-Obesity Drugs Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Anti-Obesity Drugs Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Anti-Obesity Drugs Sales Volume Market Share by Type in 2017
Table Southeast Asia Anti-Obesity Drugs Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Anti-Obesity Drugs Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Anti-Obesity Drugs Sales Volume Market Share by Application in 2017
Figure India Anti-Obesity Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure India Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Anti-Obesity Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table India Anti-Obesity Drugs Sales Volume (K Units) by Players (2013-2018)
Table India Anti-Obesity Drugs Sales Volume Market Share by Players (2013-2018)
Figure India Anti-Obesity Drugs Sales Volume Market Share by Players in 2017
Table India Anti-Obesity Drugs Sales Volume (K Units) by Type (2013-2018)
Table India Anti-Obesity Drugs Sales Volume Market Share by Type (2013-2018)
Figure India Anti-Obesity Drugs Sales Volume Market Share by Type in 2017
Table India Anti-Obesity Drugs Sales Volume (K Units) by Application (2013-2018)
Table India Anti-Obesity Drugs Sales Volume Market Share by Application (2013-2018)
Figure India Anti-Obesity Drugs Sales Volume Market Share by Application in 2017
Table Pfizer Basic Information List
Table Pfizer Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Anti-Obesity Drugs Sales Growth Rate (2013-2018)
Figure Pfizer Anti-Obesity Drugs Sales Global Market Share (2013-2018)
Figure Pfizer Anti-Obesity Drugs Revenue Global Market Share (2013-2018)
Table Merck Basic Information List
Table Merck Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Anti-Obesity Drugs Sales Growth Rate (2013-2018)
Figure Merck Anti-Obesity Drugs Sales Global Market Share (2013-2018)
Figure Merck Anti-Obesity Drugs Revenue Global Market Share (2013-2018)
Table F.Hoffmann-La Roche Basic Information List
Table F.Hoffmann-La Roche Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure F.Hoffmann-La Roche Anti-Obesity Drugs Sales Growth Rate (2013-2018)
Figure F.Hoffmann-La Roche Anti-Obesity Drugs Sales Global Market Share (2013-2018
Figure F.Hoffmann-La Roche Anti-Obesity Drugs Revenue Global Market Share (2013-2018)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Anti-Obesity Drugs Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Anti-Obesity Drugs Sales Global Market Share (2013-2018)
Figure GlaxoSmithKline Anti-Obesity Drugs Revenue Global Market Share (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Anti-Obesity Drugs Sales Growth Rate (2013-2018)
Figure AstraZeneca Anti-Obesity Drugs Sales Global Market Share (2013-2018)
Figure AstraZeneca Anti-Obesity Drugs Revenue Global Market Share (2013-2018)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Anti-Obesity Drugs Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim Anti-Obesity Drugs Sales Global Market Share (2013-2018
Figure Boehringer Ingelheim Anti-Obesity Drugs Revenue Global Market Share (2013-2018)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novo Nordisk Anti-Obesity Drugs Sales Growth Rate (2013-2018)
Figure Novo Nordisk Anti-Obesity Drugs Sales Global Market Share (2013-2018)
Figure Novo Nordisk Anti-Obesity Drugs Revenue Global Market Share (2013-2018)
Table Eisai Basic Information List
Table Eisai Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eisai Anti-Obesity Drugs Sales Growth Rate (2013-2018)
Figure Eisai Anti-Obesity Drugs Sales Global Market Share (2013-2018
Figure Eisai Anti-Obesity Drugs Revenue Global Market Share (2013-2018)
Table Norgine Basic Information List
Table Norgine Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Norgine Anti-Obesity Drugs Sales Growth Rate (2013-2018)
Figure Norgine Anti-Obesity Drugs Sales Global Market Share (2013-2018)
Figure Norgine Anti-Obesity Drugs Revenue Global Market Share (2013-2018)
Table Arena Pharmaceuticals Basic Information List
Table Arena Pharmaceuticals Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Arena Pharmaceuticals Anti-Obesity Drugs Sales Growth Rate (2013-2018)
Figure Arena Pharmaceuticals Anti-Obesity Drugs Sales Global Market Share (2013-2018)
Figure Arena Pharmaceuticals Anti-Obesity Drugs Revenue Global Market Share (2013-2018)
Table Orexigen Therapeutics Basic Information List
Table Vivus Basic Information List
Table Alizyme Basic Information List
Table Rhythm Pharmaceuticals Basic Information List
Table Shionogi Basic Information List
Table Zafgan Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Obesity Drugs
Figure Manufacturing Process Analysis of Anti-Obesity Drugs
Figure Anti-Obesity Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti-Obesity Drugs Major Players in 2017
Table Major Buyers of Anti-Obesity Drugs
Table Distributors/Traders List
Figure Global Anti-Obesity Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Anti-Obesity Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Anti-Obesity Drugs Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Anti-Obesity Drugs Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Anti-Obesity Drugs Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Anti-Obesity Drugs Sales Volume Market Share Forecast by Regions in 2025
Table Global Anti-Obesity Drugs Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Anti-Obesity Drugs Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Anti-Obesity Drugs Revenue Market Share Forecast by Regions in 2025
Figure United States Anti-Obesity Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Anti-Obesity Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Anti-Obesity Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Anti-Obesity Drugs Revenue and Growth Rate Forecast (2018-2025)
Figure Europe Anti-Obesity Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Anti-Obesity Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Anti-Obesity Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Anti-Obesity Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Anti-Obesity Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Anti-Obesity Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Anti-Obesity Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Anti-Obesity Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Anti-Obesity Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure Global Anti-Obesity Drugs Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Anti-Obesity Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Anti-Obesity Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Anti-Obesity Drugs Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Anti-Obesity Drugs Sales (K Units) Forecast by Application (2018-2025)
Figure Global Anti-Obesity Drugs Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources